These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 3873871

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Beta-lactamase stability and inhibitory activity of meropenem combined with a potent antibacterial activity.
    Nouda H, Harabe ET, Sumita Y, Okuda T, Fukasawa M.
    Chemotherapy; 1992; 38(4):218-24. PubMed ID: 1473360
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Activity of imipenem on aerobic bacteria.
    Acar JF, Goldstein FW, Kitzis MD, Gutmann L.
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():37-45. PubMed ID: 6421793
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Cefotetan: profile of in-vitro activity.
    Bauernfeind A.
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():19-29. PubMed ID: 6601656
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Preclinical evaluation of meropenem, a new parenteral carbapenem].
    Edwards JR.
    New Microbiol; 1995 Oct; 18 Suppl():19S-31S. PubMed ID: 8574929
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.
    Neu HC, Labthavikul P.
    Antimicrob Agents Chemother; 1982 Jan; 21(1):180-7. PubMed ID: 6979306
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Antibacterial properties of meropenem towards clinical isolates, beta-lactamase producers and laboratory mutants.
    Wiedemann B, Zühlsdorf M.
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():197-205. PubMed ID: 2681124
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin.
    Vuye A, Pijck J.
    Antimicrob Agents Chemother; 1985 Apr; 27(4):574-7. PubMed ID: 3859244
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. In vitro antibacterial activity of imipenem against Pseudomonas and Staphylococcus species. Comparison with thirteen other antimicrobial agents.
    Cristiano P, Abbate GF, Alagia I, Leonessa V, Giaquinto E, Savioli L.
    Drugs Exp Clin Res; 1985 Apr; 11(1):39-48. PubMed ID: 3869802
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.